Dyne Therapeutics, Inc. DYN Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dyne Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dyne Therapeutics, Inc.'s operating income?
- Dyne Therapeutics, Inc. (DYN) reported operating income of -$125.28M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s operating income changed year-over-year?
- Dyne Therapeutics, Inc.'s operating income decreased by 2.4% year-over-year, from -$122.37M to -$125.28M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s operating income?
- Over 4 years (2021 to 2025), Dyne Therapeutics, Inc.'s operating income has grown at a 32.9% compound annual growth rate (CAGR), from -$150.03M to -$468.18M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.